Document is current
Any future updates will be listed below
-
Authors
Clarke, Clare L.
Sniehotta, Falko F.
Vadiveloo, Thenmalar
Donnan, Peter T.
Witham, Miles D. https://orcid.org/0000-0002-1967-0990
-
Funding
Funding for this research was provided by:
Chief Scientist Office (CZH/4/518, CZG/2/569)
Tenovus (T15/48)
- License Information
-
More Information
Article History
First Online: 14 August 2018
Compliance with Ethical Standards
:
: Funding for this study was provided by the Chief Scientist Office, Scottish Government Grants CZH/4/518 and CZG/2/569 and Tenovus Scotland Grant number T15/48.
: Peter Donnan has received grants from Shire Pharmaceuticals, Gilead Sciences and Novo Nordisk, all outside the submitted work, and is a member of the New Drugs Committee for the Scottish Medicines Consortium. Clare Clarke, Falko Sniehotta, Thenmalar Vadiveloo and Miles Witham declare that they have no conflicts of interest potentially relevant to the content of this study.
: This study was approved by the Tayside Committee on Medical Research Ethics (09/S1401/57 and 12/ES/0016).
: Written informed consent was obtained from all study participants at baseline and at follow-up.
